S
Shola M. Richards
Researcher at Wellcome Trust Sanger Institute
Publications - 2
Citations - 1569
Shola M. Richards is an academic researcher from Wellcome Trust Sanger Institute. The author has contributed to research in topics: Ensembl & DECIPHER. The author has an hindex of 1, co-authored 1 publications receiving 1245 citations.
Papers
More filters
Journal ArticleDOI
DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources
Helen V. Firth,Shola M. Richards,A. Paul Bevan,Stephen Clayton,Manuel Corpas,Diana Rajan,Steven Van Vooren,Yves Moreau,Roger Pettett,Nigel P. Carter +9 more
TL;DR: An interactive web-based database called DECIPHER (Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources) which incorporates a suite of tools designed to aid the interpretation of submicroscopic chromosomal imbalance, inversions, and translocations.
Journal ArticleDOI
Non-invasive candidate protein signature predicts hepatic venous pressure gradient reduction in cirrhotic patients after sustained virologic response.
Shola M. Richards,Heng-Di Zou,Florian Nigsch,Anna Baiges,Alok S. Pachori,Yiming Zhang,Sabela Lens,Rebecca A. Pitts,Nancy Finkel,Joseph Loureiro,Dale Mongeon,Shenglin Ma,Mollie Watkins,Florine Polus,Agustín Albillos,Luis Téllez,J. Martínez-González,Rafael Bañares,Fanny Turon,José Ferrusquía-Acosta,Valeria Perez-Campuzano,Marta Magaz,Xavier Forns,Michael K. Badman,Andreas W. Sailer,Chinweike Ukomadu,Virginia Hernández-Gea,Juan Carlos García-Pagán +27 more
TL;DR: In this article , the authors evaluated the prognostic potential of blood-based proteomic biomarkers in predicting hepatic venous pressure gradient (HVPG) response amongst cirrhotic patients with portal hypertension due to Hepatitis C virus (HCV) and had achieved sustained virologic response (SVR).